CONTAK RENEWAL 3
A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image
(Not Necessarily related to the device)Description:
CONTAK RENEWAL 3 by Boston Scientific Corp.
The CONTAK RENEWAL 3 is a cutting-edge cardiac resynchronization therapy defibrillator (CRT-D) developed by Boston Scientific Corp. This FDA-approved device is designed to provide superior automaticity and advanced arrhythmia monitoring.
Primarily, CONTAK RENEWAL 3 is used to treat patients with advanced heart failure symptoms and reduced ejection fraction who remain symptomatic despite optimal drug therapy. It also serves those at high risk of sudden cardiac death due to previous ventricular arrhythmias or myocardial infarctions.
Benefits of CONTAK RENEWAL 3:
1. Ventilation Sensor: Monitors the patient's minute ventilation to naturally adapt to pacing rates based on metabolic needs.
2. SmartDelay™: An algorithm that proposes optimal AV/PV and VV delays to improve patient response to CRT.
3. Heart Failure Sensor Suite: Tracks physiological trends to aid in the management of heart failure patients.
4. Arrhythmia Management Features: Includes precise diagnostics for actionable insights, contributing to improved patient outcome.
Primary Use:
Introduction to CONTAK RENEWAL 3
The CONTAK RENEWAL 3 is a fundamental piece of medical technology that falls under the umbrella of Cardiac Rhythm Management Devices. Its main function is to monitor and control the rhythms of the heart for patients with irregular heart conditions.Primary Use of CONTAK RENEWAL 3
This sophisticated device is primarily used to correct ventricular and atrial arrhythmias. Arrhythmias are conditions characterized by abnormal heart rhythms. An arrhythmia can cause the heart to beat too fast, too slow, or with an irregular pattern. If such heart rhythms are not addressed, they can lead to more serious conditions such as heart failure or stroke. The CONTAK RENEWAL 3 serves as an automatic internal defibrillator, ensurinHow It Works:
How the CONTAK RENEWAL 3 Works
The CONTAK RENEWAL 3, in the subcategory of Cardiac Rhythm Management Devices, is a highly sophisticated biomedical device used in the treatment of heart diseases, specifically, those related to cardiac rhythm disturbances.This device is primarily designed to regulate the rhythm of the heart by delivering appropriate electrical impulses, counteracting abnormal heart rhythms known as arrhythmias.
Operation of CONTAK RENEWAL 3
CONTAK RENEWAL 3 functions as an implantable cardioverter-defibrillator (ICD) with Cardiac Resynchronization Therapy (CRT); its dual operation has revolutionized the management of heart disorders.As an ICD, the device monitors the heart rhythm continuously. When it detects life-threatening, rapid heart rhythms, known as ventricular fibrillation or ventricular tachycardia, the CONTAK RENEWAL 3 can deliver either painless pacing or a shock to correct the rhythm.
Adding the benefit of CRT, the CONTAK RENEWAL 3 also improves the efficiency of the heart. CRT function is chiefly beneficial for patients suffering from heart failure, a condition where the heart's pumping ability is compromised. This therapy operates by coordinating the pumping action of the heart's chambers, resulting in the better overall performance of the heart.
Final Thoughts
CONTAK RENEWAL 3 is a robust and versatile cardiac rhythm management device that provides comprehensive care for patients suffering from heart rhythm abnormalities and heart failure. This life-saving device is a testament to how advancements in medical technology can enhance the quality of patients' lives.Manufacturer:
Boston Scientific Corp.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.